Family Medicine Doctors in New Glarus, WI Accepting Medicare
2 Family Medicine doctors found. Showing 1 - 2
 Dr. John Nicholas Gietzen, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: W5491 Windmill Ridge Rd, New Glarus, WI 53574 Phone: 608-518-3654 Fax: 928-277-4942 |
Gaines E Richardson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1800 2nd St, New Glarus, WI 53574 Phone: 608-527-5296 |
News Archive
Lower rate of reintubation observed in infants receiving SURFAXIN
Discovery Laboratories, Inc. today announced the presentation of a new pharmacoeconomic analysis demonstrating that the lower rate of reintubation previously reported in infants treated with SURFAXIN, when compared with infants treated with Curosurf® and Survanta®, the current global market leading surfactants, also resulted in a potential hospital cost savings of $160,000 to $252,000 per 100 infants.
Gene therapy for pain
Researchers in the Department of Medicine and Department of Neurosciences at Mount Sinai School of Medicine have discovered that chronic pain can be successfully treated with novel targeted gene therapy.
Insilico to present latest research on biomarkers at Investing in the Age of Longevity Conference
Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest advances in human aging biomarker development at the Investing in the Age of Longevity Conference in London, 1 of November.
Waters introduces new TQ-S and G2 QTof mass spectrometers for Xevo MS platform
Waters Corporation introduced today two new mass spectrometers for its Xevo MS platform – the Xevo TQ-S and Xevo G2 QTof – that bring a step change in performance to benchtop mass spectrometry. The product introductions were made at the 58th annual meeting of the American Society for Mass Spectrometry (ASMS).
Rhythm, Actavis announce initiation of relamorelin Phase 2b trial for treatment of diabetic gastroparesis
Rhythm, a biopharmaceutical company, and Actavis plc, a leading global pharmaceutical company, announced today the initiation of a Phase 2b clinical trial assessing the efficacy and safety of relamorelin (RM-131), Rhythm's ghrelin agonist, for the treatment of gastroparesis in patients with type 1 and type 2 diabetes.
› Verified 4 days ago